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Abstract
Background: To support decisions about surgical treatment of elderly patients with cancer,
population-based estimates of postoperative mortality (POM) rates are required.
Methods: Electronic records from the Rotterdam Cancer Registry were retrieved for
octogenarians and nonagenarians who underwent resection in the period 1987–2000. POM was
defined as death within 30 days of resection and both elective and emergency operations were
included.
Results: In a series of 5.390 operated patients aged 80 years and older, POM rates were 0.5% for
breast cancer, 1.7% for endometrial cancer and 4.2% for renal cancer. For patients with colorectal
cancer, POM increased from 8% for the age group 80–84 to 13% for those 85–89 to 20% in
nonagenarians. For stomach cancer, the respective figures were 11%, 20% and 44%.
Conclusion: These results show that resections can be performed at acceptable risk in selected
elderly patients with cancer.
Background
As a result of ageing of the general population, the propor-
tion of elderly patients with cancer is increasing within
Europe. In the Netherlands, 14% of male patients and
17% of female patients are 80 years or older at diagnosis
[1]. In the elderly, relative survival is generally worse than
in younger patients [2], mainly due to a more advanced
stage at diagnosis or due to less extensive treatment. Espe-
cially surgery is withheld out of concern for postoperative
morbidity and mortality. Many studies, however, suggest
that surgical treatment can be performed at acceptable risk
and with good results. These reports usually come from
specialized centres with selected series and may be too
optimistic due to reporting and publication bias. To sup-
port decisions about the option of surgical treatment in a
general situation, we studied postoperative mortality rates
using data from a population-based cancer registry.
Methods
Information on octogenarians and nonagenarians who
underwent resection for cancer in the period 1987–2000
was retrieved from the Rotterdam Cancer Registry. The
Rotterdam Cancer Registry is operational since 1982 and
now covers a region with one university hospital, 15 gen-
eral hospitals and 2.3 million inhabitants. Trained coding
clerks collect information on tumour site and morphol-
ogy, tumour stage and type of treatment. The clinical
record is assessed at least 3 months after diagnosis and
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tive mortality, which was defined as death within 30 days
of operation. Due to privacy regulations death certificates
are not available, thus hampering evaluation of long-term
survival.
This study comprises all consecutive patients who under-
went primary resection of the tumour, irrespective of the
type of surgery, whether being elective, emergency, cura-
tive or palliative. To avoid chance findings, the study was
restricted to types of cancer with more than 100 patients
operated. Subgroup analysis by age was only performed
for types of cancer with more than 10 postoperative
deaths per subgroup. Postoperative mortality rates were
tabulated and differences between subgroups were evalu-
ated with chi-square test.
Results
This study comprises 5,390 patients who underwent
resectional surgery between 1987 and 2000. Postoperative
mortality increased with age from 5.4% in patients aged
80 to 84 years, to 9.1% in patients aged 85 to 89 years and
to 14.4% in nonagenarians (Table 1). In more recent
years, a small decrease in postoperative mortality was
observed, from 7.7% in the period 1987–1993 to 6.5% in
the period 1994–2000 (p = 0.07).
Colorectal cancer and breast cancer were the most com-
mon types of cancer with postoperative mortality rates of
10.6% and 0.5%, respectively. Postoperative mortality
was highest for stomach cancer with 15.8%. For endome-
trial cancer and kidney cancer, postoperative mortality
rates were 1.7% and 4.2%, respectively.
For colorectal cancer, postoperative mortality rates
increased from 8% in patients aged 80 to 84 years, to 13%
in patients aged 85 to 89 years and to 20% in nonagenar-
ians (p < 0.001) (Table 2). For stomach cancer the respec-
tive figures were 11%, 20% and 44% (p < 0.001).
Discussion
Our results show that resectional surgery can be per-
formed at acceptable risk in elderly patients with cancer. It
is unknown whether these results can be generalised to
other regions, time periods or health care systems. Popu-
lation-based studies tend to report higher operative mor-
tality rates than studies from single institutions. Selection
criteria are presumably different from those in trial series
and publication bias hampers honest comparison. Even
between population-based studies, selection criteria and
definitions may differ. For example, a study from the US
[3] analysed operative mortality in patients aged 85 years
and older and reported on gastrectomy (16%), colectomy
(7%) and nephrectomy (5%), but only included elective
Table 1: Postoperative mortality (POM) in octogenarians and nonagenarians who underwent resectional surgery for cancer
Postoperative mortality
No. of patients No. of deaths %
Sex Male 1385 184 13.3
Female 4005 196 4.9
Age (years) 80–84 3513 190 5.4
85–89 1503 136 9.1
90+ 374 54 14.4
Period 1987–1993 2415 187 7.7
1994–2000 2975 193 6.5
Type of cancer Colorectal 2765 293 10.6
Stomach 424 67 15.8
Breast 1731 9 0.5
Endometrial 350 6 1.7
Kidney 120 5 4.2
Table 2: Postoperative mortality for octogenarians and nonagenarians with colorectal or stomach cancer.
Type of cancer 80–84 years 85–89 years 90+ years
n POM (%) n POM (%) n POM (%) p-value
Colorectal 1731 8 837 13 197 20 <0.001
Stomach 293 11 99 20 32 44 <0.001Page 2 of 3
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may not be attributable to the resection itself because
some patients would also have died after alternative treat-
ment. A second difference is that the US study reported on
in-hospital mortality, which produces higher rates than
the 30-day definition.
Age-specific reference figures are essential for clinical deci-
sion-making but calendar age serves as a poor substitute
for biological age, which in itself is difficult to define or
determine [4]. Preoperative assessment of the operative
risk in geriatric patients is considered very important but
current scoring methods provide little assistance [5]. As a
consequence, treatment decisions in the elderly cannot be
based on general guidelines but will rather require tai-
lored plans that need to be discussed with the patient and
his or her family. In some cases, surgery may need to be
postponed for the treatment of concomitant disease.
Apart from operative mortality, the remaining quality of
life and the life expectancy should be taken into consider-
ation. Non-fatal complications and lengthy hospital stays
should not be taken too lightly and may severely impair
daily living. The median life expectancy for men and
women aged 90 years, is 3.3 and 4.1 years, respectively.
The actual life expectancy, however, is difficult to predict
and little is known about the course of cancer after subop-
timal treatment. Especially in the elderly, preoperative
assessment of the extent of disease is crucial to avoid
senseless palliative surgery.
For breast cancer, studies have shown that primary hor-
monal treatment is inferior to direct surgery [6], which is
understandable given the low operative risk. For endome-
trial cancer, the operative risk is less than 2% and alterna-
tive treatments should be reserved for patients with severe
comorbidity. For kidney cancer, nephrectomy should be
considered when urinary function is acceptable, but can-
cer progression may be slow and a wait-and-see policy is
a serious option in patients with smaller lesions. For
abdominal surgery, the operative risk is substantial but
this risk may still be worthwhile given the absence of
other curative options. Whether an operative risk of 44%
in nonagenarians with stomach cancer is ethically accept-
able, is up to discussion. However, when faced with a
guarantee of progressive cancer and no alternatives for
cure, patients are willing to accept extremely high-risks [7]
that may even seem unacceptable to their physician. For
abdominal tumours, emergency presentation is more
common in the elderly and obstruction may lead to a
quick death in case of non-surgical treatment. Laparo-
scopic interventions may, however, avert major surgery.
Conclusion
In the near future, the number of elderly patients with
cancer will continue to rise due to the ageing of the gen-
eral population. Judging from the current findings, sur-
gery should not be withheld because of the postoperative
mortality but suboptimal or palliative treatment may be
necessary in patients with poor physical or mental func-
tion. To enable informed decision-making, both patients
and clinicians need information on the risks of surgical
treatment. This information should be retrieved from
population based studies since we cannot rely on the
memory of individual clinicians, as is shown by the nine
deaths after surgery for breast cancer in a consecutive
series of 1731 patients in 15 hospitals over a period of 14
years. Finally, we want to stress the importance of studies
incorporating comprehensive geriatric assessment that
may provide us with better estimates of the operative risk
in the future [8].
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